Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Check-Cap Ltd

Check-Cap Ltd (CHEKZ) Stock Overview

Explore Check-Cap Ltd’s financial performance, market position, analyst ratings, and future outlook.

CHEKZ●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.01
$0.00(0.00%)
U.S. Market opens in 12h 45m

Check-Cap Ltd (CHEKZ)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio1.98
EPS (TTM)N/A
ROE4.17%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

CHEKZ Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Check-Cap Ltd (NASDAQ: CHEKZ) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Check-Cap Ltd's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CHEKZ on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Check-Cap Ltd's NASDAQ-traded stock include a P/E ratio of 1.98 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of CHEKZ on the NASDAQ.

Price Performance (NASDAQ: CHEKZ)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-22.90%
3-Month Change
-65.05%
6-Month Change
-56.65%
Year-to-Date (YTD) Change
-56.09%
1-Year Change
-85.41%
3-Year Change
-79.80%
5-Year Change
-98.65%
All-Time (Max) Change
-98.74%

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

IPO DateMay 4, 2018
CountryUS

Frequently Asked Questions